Publications

March 2020
Article

A Revolution in Economics? It's Just Getting Started...

By: Shawn A. Cole, William Pariente and Anja Sautmann

We have each experienced thrills and pain while supporting the mission of the Abdul Latif Jameel Poverty Action Lab, which facilitated many of the experiments described in the 2019 Nobel Prize citation. J-PAL in many ways seeks to fulfill what Angrist and Pischke... View Details

Keywords: Randomized Control Trials; Economics; Research; Innovation and Invention

Register to Read

November 2020
Case

Wilderness Safaris: Responses to the COVID-19 Crisis

By: James E. Austin, Megan Epler Wood and Herman B. "Dutch" Leonard

This case is an epilogue to “Wilderness Safaris: Impact Investing and Ecotourism Conservation in Africa” (2-321-020), which ends with the emergence of the pandemic in March 2020. The final discussion area for that case can be “What should Wilderness Safari CEO Keith... View Details

Keywords: Communities; COVID-19; Ecotourism; Travel; Travel Industry; Conservation Planning; Reopening; Investor Relations; Project Strategy; Governance; Decision Making; Cash; Health Pandemics; Business and Shareholder Relations; Tourism Industry; Africa

11 Mar 2008
Working Paper Summaries

Finding Missing Markets (and a disturbing epilogue): Evidence from an Export Crop Adoption and Marketing Intervention in Kenya

Keywords: by Nava Ashraf, Xavier Giné & Dean Karlan; Food & Beverage

March 2016
Article

Using Quality Improvement Methods and Time-Driven Activity-Based Costing to Improve Value-Based Cancer Care Delivery at a Cancer Genetics Clinic

By: R.Y. Tan, M. Met-Domestici, K. Zhou, A.B. Guzman, S.T. Lim, K.C. Soo, T.W. Feeley and J. Ngeow

Purpose:
To meet increasing demand for cancer genetic testing and improve value-based cancer care delivery, National Cancer Centre Singapore restructured the Cancer Genetics Service in 2014. Care delivery processes were redesigned. We sought to improve access by... View Details

Keywords: Cancer Treatment; Value Based Health Care; Time-Driven Activity-Based Costing; Health Care and Treatment; Quality; Performance Improvement; Activity Based Costing and Management

2023
Other Article

The Harvard USPTO Patent Dataset: A Large-Scale, Well-Structured, and Multi-Purpose Corpus of Patent Applications

By: Mirac Suzgun, Luke Melas-Kyriazi, Suproteem K. Sarkar, Scott Duke Kominers and Stuart Shieber

Innovation is a major driver of economic and social development, and information about many kinds of innovation is embedded in semi-structured data from patents and patent applications. Though the impact and novelty of innovations expressed in patent data are difficult... View Details

Keywords: USPTO; Natural Language Processing; Classification; Summarization; Patent Novelty; Patent Trolls; Patent Enforceability; Patents; Innovation and Invention; Intellectual Property; AI and Machine Learning; Analytics and Data Science

28 Apr 2021
Blog Post

Alumni Spotlight: Cissy Chen (MBA 2019)

values taught in this class within the firm. In these HBS courses and in the work you have pursued, you have gained perspective on ESG frameworks and their application to the markets in Asia. Can you provide an example of how you’ve applied ESG frameworks to View Details

30 Jan 2018
First Look

January 30, 2018

evaluating energy policy. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=53813 Zig-Zagging Your Way to Transformative Impact By: Rangan, V. Kasturi, and Tricia Gregg... View Details

Keywords: Sean Silverthorne

May 2021
Article

Value-Based Healthcare in Urology: A Collaborative Review

By: Chanan Reitblat, Paul A. Bain, Michael E. Porter, David N. Bernstein, Thomas W. Feeley, Markus Graefen, Santosh Iyer, Matthew J. Resnick, C.J. Stimson, Quoc-Dien Trinh and Boris Gershman

Context:
In response to growing concerns over rising costs and major variation in quality, improving value for patients has been proposed as a fundamentally new strategy for how healthcare should be delivered, measured, and... View Details

Keywords: Value-based Healthcare; Integrated Practice Units; Outcome Measurement; Time-Driven Activity-Based Costing; Health Care and Treatment; Value; Cost Management; Strategy; Outcome or Result; Measurement and Metrics

Web

Faculty & Research

for acute symptoms, more than improving patient education, may reduce avoidable health care. Featured Case Blue Owl Financing of Ping Identity By: Victoria Ivashina and Srimayi Mylavarapu In the fall of 2022, Blue Owl Capital's investment committee View Details

2012
Working Paper

Clusters, Convergence, and Economic Performance

By: Mercedes Delgado, Michael E. Porter and Scott Stern

This paper evaluates the role of regional cluster composition in the economic performance of industries, clusters, and regions. On the one hand, diminishing returns to specialization in a location can result in a convergence effect: the growth rate of an industry... View Details

Keywords: Industry Clusters; Performance; Economics

November 2015
Article

Influence of Experience and the Surgical Learning Curve on Long-term Patient Outcomes in Cardiac Surgery

By: Bryan M. Burt, Andrew W. ElBardissi, Robert S. Huckman, Lawrence H. Cohn, Marisa W. Cevasco, James D. Rawn, Sary F. Aranki and John G. Byrne

OBJECTIVE: We hypothesized that increased post-graduate surgical experience correlates with improved operative efficiency and long-term survival in standard cardiac surgery procedures.

METHODS: Utilizing a prospectively collected retrospective database,... View Details

Keywords: Service Delivery; Value; Health Care and Treatment; Experience and Expertise; Health Industry

January 2020
Case

Sunset Limited or Full Speed Ahead? Amtrak Talks to Congress

By: John D. Macomber

Richard Anderson took the helm of Amtrak in 2017 after leading a successful turnaround at Delta Airlines. Amtrak is a US state owned enterprise with about $3.5 bn in annual revenue (and a large operating loss) that is responsible for substantial segments of passenger... View Details

Keywords: Railroad; Passenger Transportation; Urbanization; Cities; U.S. Congress; Infrastructure; Transition; Transportation; Rail Transportation; Climate Change; Urban Scope; Strategic Planning; Business and Government Relations; Rail Industry; United States

September 2023 (Revised October 2024)
Case

Forecasting Climate Risks: Aviva’s Climate Calculus

By: Mark Egan and Peter Tufano

In late 2021, Ben Carr, Director of Analytics and Capital Modeling at Aviva Plc (Aviva)—a leading insurer with core operations in the UK, Ireland and Canada,—was preparing for an upcoming presentation before the company's board which included its CEO, Amanda Blanc,... View Details

Keywords: Climate Risk; Climate Finance; Forecasting; Insurance; Risk Measurement; Climate Change; Risk Management; Forecasting and Prediction; Insurance Industry; United States

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry

June 2022
Case

Michelin’s Green Gold Bahia Program: Leaving With Grace

By: Sandra J. Sucher, Shalene Gupta and Susan J. Winterberg

In 2015, the top management of French tire-maker Michelin, was evaluating Michelin’s approach to divesting its rubber plantations ten years after incorporating a novel strategy.
In 2004, Michelin had a Brazilian rubber challenge. Its Bahía plantation had been hit... View Details

Keywords: Divestment; Supply Chain Management; Natural Resources; Corporate Accountability; Corporate Social Responsibility and Impact; Rubber Industry; Auto Industry; Brazil; France